Gabapentin Capsule
Product Images NDC 50090-0949

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-0949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Fig1)

This text appears to be a calculation formula for determining a value related to creatinine levels in female patients based on their age and weight. Specifically, it involves multiplying the patient's age in years by their weight in kilograms and then multiplying the result by 0.85 (which may be a correction factor for female patients). The resulting value is referred to as "Lt" and likely has some significance in medical contexts related to creatinine testing.*

FDA Label Image

Figure 1 (Gabapentin Fig2)

The text seems to be a chart or graph displaying the mean pain score for a study involving a placebo and gabapentin at 3600 mg/day. The chart also includes a baseline measurement and spans over a period of 7 weeks, divided into a titration period and a fixed dose period. The data is presented numerically on a scale of 1 to 10.*

FDA Label Image

Figure 2 (Gabapentin Fig3)

The text appears to be a chart displaying pain scores and dosage periods of a medication called Gabapentin. It also includes a placebo group and a baseline measurement. The chart shows that over a 4-week period, the group taking Gabapentin at a dosage of 2400mg/day had the lowest pain score.*

FDA Label Image

Figure 3 (Gabapentin Fig4)

The text shows a graph presenting the proportion of responders in controlled PHN studies for patients with at least a 50% reduction in pain score. The graph compares two studies, Study 1 and Study 2, showing the percentage of patients who responded in each group. The figures 100%, 70%, 50%, and 30% appear on the graph vertically. The text "#p<00l 5D < 0,001" likely indicates the statistical significance of the results. The remaining text appears to be a table showing the percentage of responders for each treatment group (placebo, GBP 3600, GBP 1800, and GBP 2400).*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

FDA Label Image

Chemical Structure (Gabapentin Str)

FDA Label Image

Label Image (Lbl500900949)

This is a product label with the product number 5734-0, containing 166mg of a substance called GharsentIn. It comes in a container with 30 capsules and the recommended storage temperature is 8°C to 10°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.